A detailed history of Exodus Point Capital Management, LP transactions in Nevro Corp stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 126,359 shares of NVRO stock, worth $676,020. This represents 0.01% of its overall portfolio holdings.

Number of Shares
126,359
Previous 342,477 63.1%
Holding current value
$676,020
Previous $4.95 Million 78.48%
% of portfolio
0.01%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$7.96 - $13.59 $1.72 Million - $2.94 Million
-216,118 Reduced 63.1%
126,359 $1.06 Million
Q1 2024

May 14, 2024

BUY
$13.56 - $20.78 $4.64 Million - $7.12 Million
342,477 New
342,477 $4.95 Million
Q2 2023

Aug 10, 2023

SELL
$22.62 - $39.32 $942,145 - $1.64 Million
-41,651 Reduced 71.39%
16,689 $424,000
Q1 2023

May 11, 2023

BUY
$30.17 - $41.11 $245,070 - $333,936
8,123 Added 16.18%
58,340 $2.11 Million
Q4 2022

Feb 13, 2023

SELL
$36.43 - $49.4 $136,466 - $185,052
-3,746 Reduced 6.94%
50,217 $1.99 Million
Q3 2022

Nov 10, 2022

SELL
$40.66 - $53.03 $62,250 - $81,188
-1,531 Reduced 2.76%
53,963 $2.52 Million
Q2 2022

Aug 19, 2022

BUY
$40.85 - $77.67 $2.27 Million - $4.31 Million
55,494 New
55,494 $2.43 Million
Q1 2022

May 13, 2022

SELL
$59.95 - $92.06 $665,804 - $1.02 Million
-11,106 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$81.07 - $121.29 $731,251 - $1.09 Million
9,020 Added 432.41%
11,106 $900,000
Q3 2021

Nov 15, 2021

BUY
$101.99 - $166.36 $212,751 - $347,026
2,086 New
2,086 $243,000
Q2 2021

Aug 16, 2021

SELL
$141.6 - $179.06 $1.46 Million - $1.85 Million
-10,343 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$132.81 - $182.18 $1.37 Million - $1.88 Million
10,343 New
10,343 $1.44 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $189M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.